KMUP-1 protects against streptozotocin-induced mesenteric artery dysfunction via activation of ATP-sensitive potassium channels

Pharmacol Rep. 2018 Aug;70(4):746-752. doi: 10.1016/j.pharep.2018.02.017. Epub 2018 Feb 21.

Abstract

Background: Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia accompanied by impaired vascular and endothelial function. Activation of ATP-sensitive potassium (KATP) channels can protect endothelial function against hypertension and hyperglycemia. KMUP-1, a xanthine derivative, has been demonstrated to modulate K+-channel activity in smooth muscles. This study investigated protective mechanisms of KMUP-1 in impaired mesenteric artery (MA) reactivity in streptozotocin (STZ)-induced diabetic rats.

Methods: Rats were divided into three groups: control, STZ (65 mg/kg, ip) and STZ + KMUP-1 (5 or 10 mg/kg/day, ip). MA reactivity was measured by dual wire myograph. MA smooth muscle cells (MASMCs) were enzymatically dissociated and the KATP currents recorded by a whole-cell patch-clamp technique.

Results: STZ decreased MA KATP currents in a time-course dependent manner and achieved steady inhibition at day 14. In the MASMCs of STZ-treated rats, KMUP-1 partially recovered the KATP currents, suggesting that vascular KATP channels were activated by KMUP-1. K+ (80 mM KCl)-induced MA contractions in STZ-treated rats were higher than those of control rats. KMUP-1 significantly attenuated STZ-stimulated MA contractions in response to high K+, suggesting that KMUP-1 may partly restore the vascular reactivity of MAs. In addition, STZ decreased the expression of endothelial nitric oxide synthase (eNOS) and this effect was reversed by KMUP-1, suggesting that KMUP-1 could improve STZ-induced vascular endothelial dysfunction.

Conclusion: KMUP-1 prevents STZ impairment of MA reactivity, eNOS levels and KATP channels, and accordingly protects against vascular dysfunction in diabetic rats.

Keywords: K(ATP) channels; Mesenteric artery; Patch-clamp technique; Streptozotocin; Vascular dysfunction.

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental / complications*
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / physiopathology*
  • Dose-Response Relationship, Drug
  • KATP Channels / metabolism*
  • Male
  • Membrane Potentials / physiology
  • Mesenteric Arteries / metabolism
  • Mesenteric Arteries / physiopathology*
  • Myocytes, Smooth Muscle / physiology
  • Nitric Oxide Synthase Type III / biosynthesis
  • Piperidines / pharmacology*
  • Potassium / pharmacology
  • Rats
  • Time Factors
  • Vascular Diseases / complications*
  • Vascular Diseases / metabolism
  • Vascular Diseases / physiopathology
  • Vascular Diseases / prevention & control*
  • Xanthines / pharmacology*

Substances

  • KATP Channels
  • Piperidines
  • Xanthines
  • KMUP 1
  • Nitric Oxide Synthase Type III
  • Potassium